As indicated below in April 2016 Phosphagenics and Terumo entered into an 18 month arrangement for a propofol injectable development.This currently only leaves about 4 months for this agreement to run.According to Future Market Insights[FMI] propofol accounts for nearly one-third of the global anasthesia market and is expected to expand at CAGR of over 5% through 2025.
"As part of the R&D alliance the companies have also agreed to collaborate on the global development of three additional pharmaceutical products leveraging Phosphagenics’ proprietary TPM® technology: a TPM®/Propofol injection building on the prototype already developed at Phosphagenics and two additional novel TPM® containing pharmaceutical products"
Kens
Terumo and Propofol Injectable
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.439K | 479.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 81795927 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 33320021 | 21 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.3¢ |
Change
-0.001 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.3¢ | 215316 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| AVE (ASX) Chart |